MB
Martin Brenner
See RemarksDirector

Martin Brenner insider trades: iBio (IBIO) stock buys and sales

See Remarks, iBio Last trade Mar 19, 2026 27 Form 4 filings
$0
Sold, last 12 months
0 sales
$25K
Bought, last 12 months
1 buy
13
Open-market trades
since 2023
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Martin reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 19, 2026IBIO↑ Buy$25K
Jan 10, 2025IBIO↑ Buy$25K
Nov 1, 2023IBIO↓ Sell$1K
Oct 3, 2023IBIO↓ Sell$2K
Oct 2, 2023IBIO↓ Sell$1K
Aug 28, 2023IBIO↓ Sell$2K
Jul 27, 2023IBIO↓ Sell$2K
Jul 12, 2023IBIO↓ Sell$28K
Jun 21, 2023IBIO↓ Sell$3K
May 22, 2023IBIO↓ Sell$4K
Apr 24, 2023IBIO↓ Sell$5K
Mar 23, 2023IBIO↓ Sell$11K
Feb 21, 2023IBIO↓ Sell$7K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other IBIO insiders

Open-market trades in the last 12 months

About Martin Brenner's insider trades

Martin Brenner is See Remarks at iBio (IBIO). Since Feb 21, 2023, Martin has reported 2 open-market purchases worth $50K and 11 sales worth $66K on SEC Form 4. In the last 12 months: 1 buy ($25K).

Their filings also include grants and awards (13 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IBIO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.